" class="no-js "lang="en-US"> Lunit - Medtech Alert
Saturday, March 25, 2023

Breaking News

Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Celyad Oncology Appoints Georges Rawadi as Its New CEO Companion Spine Closes $60.1 Million Series A Funding Round EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare Genprex CEO Commends FDA’s Initiative to Accelerate Approval Process for Gene Therapies OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases
Lunit | Pharmtech Focus

Lunit

About Lunit

Lunit

Lunit, abbreviated from “learning unit,” is a Medical AI software company devoted to developing advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology.

Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical images. Lunit is based in Seoul, South Korea.

Related Story

News

 Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution | MTA

Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution

March 20 2023

Lunit, a leading global provider of AI-powered cancer solutions, today announced that its AI solution […]

Artificial Intelligence

 Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors | Pharmtech Focus

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

November 25 2021

Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising […]

Artificial Intelligence

 AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round | Pharmtech Focus

AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round

July 20 2021

Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of […]